Action for first-line PD-1 inhibitors in paediatric Hodgkin lymphoma.
- DOI
- 10.1016/s0140-6736(25)02386-4
- Published
- 2026 Jan 10
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-25-02386-4,
title = {Action for first-line PD-1 inhibitors in paediatric Hodgkin lymphoma.},
author = {Ceppi F and Veening M and Mascarin M and Balwierz W and Mauz-Koerholz C and European Network for Pediatric Hodgkin Lymphoma Consortium},
year = {2026},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(25)02386-4},
url = {https://doi.org/10.1016/s0140-6736(25)02386-4}
}RIS
TY - JOUR TI - Action for first-line PD-1 inhibitors in paediatric Hodgkin lymphoma. AU - Ceppi F AU - Veening M AU - Mascarin M AU - Balwierz W AU - Mauz-Koerholz C AU - European Network for Pediatric Hodgkin Lymphoma Consortium PY - 2026 JO - Lancet (London, England) DO - 10.1016/s0140-6736(25)02386-4 UR - https://doi.org/10.1016/s0140-6736(25)02386-4 ER -
APA
F, C., M, V., M, M., W, B., C, M., & Consortium, E. N. F. P. H. L. (2026). Action for first-line PD-1 inhibitors in paediatric Hodgkin lymphoma.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)02386-4
Source records
- pubmed · retrieved 2026-09-27T16:54:33.691Z
- europe-pmc · retrieved 2026-09-27T16:54:33.698Z